Sanofi SA (SNY)

46.32 +0.91 (+2.00%) USD  |  NASDAQ  |  Apr 19, 16:00
46.29 -0.03 (-0.06%) After-Hours: 20:00
More

Sanofi Cash and Short Term Investments (Quarterly): 9.926B for Dec. 31, 2023

Cash and Short Term Investments (Quarterly) Chart

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2002. Upgrade now.
Date Value
December 31, 2023 9.926B
June 30, 2023 8.686B
December 31, 2022 14.37B
June 30, 2022 7.207B
December 31, 2021 12.63B
June 30, 2021 11.57B
June 30, 2020 17.96B
December 31, 2019 11.04B
June 30, 2019 7.666B
December 31, 2018 8.149B
June 30, 2018 8.663B
December 31, 2017 12.47B
December 31, 2016 10.89B
December 31, 2015 10.02B
June 30, 2015 5.526B
December 31, 2014 8.938B
June 30, 2014 5.967B
December 31, 2013 11.48B
June 30, 2013 5.556B
December 31, 2012 8.513B
June 30, 2012 5.770B
Date Value
December 31, 2011 5.387B
June 30, 2011 9.632B
December 31, 2010 8.629B
June 30, 2010 4.160B
December 31, 2009 7.106B
June 30, 2009 8.988B
December 31, 2008 6.469B
June 30, 2008 1.491B
December 31, 2007 2.619B
June 30, 2007 1.593B
December 31, 2006 1.664B
June 30, 2006 1.930B
December 31, 2005 1.845B
June 30, 2005 3.289B
December 31, 2004 3.372B
June 30, 2004 3.915B
December 31, 2003 4.244B
June 30, 2003 2.614B
December 31, 2002 3.242B
June 30, 2002 3.018B

Cash and Short Term Investments Definition

Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

7.207B
Minimum
Jun 2022
17.96B
Maximum
Jun 2020
11.23B
Average
11.04B
Median
Dec 2019

Cash and Short Term Investments (Quarterly) Benchmarks

AstraZeneca PLC 5.86B
GSK PLC 6.359B
Novo Nordisk A/S 4.488B
Regeneron Pharmaceuticals Inc 10.84B
Inhibrx Inc 277.92M